Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Lurkin, Antoine ^a,b   Ducimetière, Francoise ^a,b   Vince, Dominique R ^a   Decouvelaere, Anne Valérie ^a   Cellier, Dominic ^g   Gilly, François N ^d   Salameire, Dimitri ^e   Biron, Pierre ^a,b,c   de Laroche, Guy ^c,d,e,f   Blay, Jean Y ^{a,b,c,d,e,f,g,h}   Ray Coquard, Isabelle ^a,b  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ DE LYON   (France)

^c ONCORA network   (France)

^d CHU A Michallon ^*  (France)

^e HÔPITAL MICHALLON   (France)

^f Institut de Cancerologie de la Loire   (France)

^g Merck KGaA France   (France)

^h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FRANCE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL EXPERT; OBSERVER VARIATION; PATHOLOGIST; POLYMERASE CHAIN REACTION; SARCOMA; TUMOR BIOPSY; CASE CONTROL STUDY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOMA; YOUNG ADULT;

EID: 77950923961     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-150     Document Type: Article

References (39)

1. Menegoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buemi A, et al. Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev 1997, 6(5):442-66.
2. Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med 2005, 353(7):701-11. 10.1056/NEJMra041866, 16107623.
3. Ray-Coquard I, Thiesse P, Ranchere-Vince D, Chauvin F, Bobin JY, Sunyach MP, et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol 2004, 15(2):307-15. 10.1093/annonc/mdh058, 14760127.
4. Fletcher CD, Unni KK, Mertens F. WHO classification of tumors. Pathology and genetics. Tumors of Soft Tissue and Bone 2002, IARC press.
5. Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19(Suppl 2):ii89-ii93. 10.1093/annonc/mdn101, 18456783.
6. Arbiser ZK, Folpe AL, Weiss SW. Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol 2001, 116(4):473-6. 10.1309/425H-NW4W-XC9A-005H, 11601130.
7. Coindre JM, Nguyen BB, Goussot JF, De MI, Maree D, De Mascarel A, et al. [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann Pathol 1985, 5(2):95-9.
8. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986, 58(2):306-9. 10.1002/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO;2-7, 3719523.
9. Harris M, Hartley AL, Blair V, Birch JM, Banerjee SS, Freemont AJ, et al. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer 1991, 64(2):315-20. 1977501, 1892759.
10. Katenkamp D. Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas. Pathol Res Pract 1988, 183(6):698-705.
11. Tomaszewski JE, Bear HD, Connally JA, Epstein JI, Feldman M, Foucar K, et al. Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol 2000, 114(3):329-35.
12. Lind AC, Bewtra C, Healy JC, Sims KL. Prospective peer review in surgical pathology. Am J Clin Pathol 1995, 104(5):560-6.
13. Kronz JD, Westra WH, Epstein JI. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999, 86(11):2426-35. 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3, 10590387.
14. Ducimetiere A, Lurkin D, Ranchere-Vince P, Biron M, Peoch L, Istier D, Salameire P, Chalabreysse J, Blay Y, Ray-Coquard I. Exhaustive prospective collection of new sarcomas: Report of an unexpectedly high incidence. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2007, 25(No 18S (June 20 Supplement)):20513.
15. Berger C, Trombert-Paviot B, Mitton N, Frappaz D, Galambrun C, Plantaz D, et al. [Childhood cancer incidence and survival rates in the Rhone-Alpes regional paediatric registry 1987-1999]. Arch Pediatr 2006, 13(2):121-9. 10.1016/j.arcped.2005.10.022, 16376530.
16. Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P. Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer 2008, 50(6):1213-20. 10.1002/pbc.21506, 18300318.
17. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997, 15(1):350-62.
18. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20:27-46.
19. Fleiss JL, Cohen J, Everitt BS. Large sample standard errors of kappa and weighted kappa. Psychol Bull 1969, 72:323-327.
20. Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995, 221(2):185-95. 10.1097/00000658-199502000-00009, 1234952, 7857146.
21. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996, 14(4):1201-8.
22. Enzinger FM. Soft tissue tumours. 2001, Weiss SW. St Louis: Mosby, 4.
23. Reichardt P. High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol 2002, 41(2):157-67. 10.1016/S1040-8428(01)00153-6, 11856592.
24. Coindre JM. [Recommendations for anatamo-pathologic management of soft tissue sarcomas in the adult. Pathologists of the FNCLCC Sarcoma Group (Federation Nationale des Centres de Lutte Contre le Cancer)]. Ann Pathol 1998, 18(6):505-11.
25. Coindre JM. Histologic grading of adult soft tissue sarcomas. Verh Dtsch Ges Pathol 1998, 82:59-63.
26. Hasegawa T, Yamamoto S, Nojima T, Hirose T, Nikaido T, Yamashiro K, et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 2002, 33(1):111-5. 10.1053/hupa.2002.30184, 11823981.
27. Lehnhardt M, Daigeler A, Hauser J, Puls A, Soimaru C, Kuhnen C, et al. The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol 2008, 97(1):40-3. 10.1002/jso.20897, 17918224.
28. Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol 2000, 29(5):249-58. 10.1007/s002560050603, 10883443.
29. Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 2003, 43(1):1-16. 10.1046/j.1365-2559.2003.01639.x, 12823707.
30. Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 2000, 31(5):532-8. 10.1053/hp.2000.6706, 10836292.
31. Ordóñez NG. Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol 1998, 5:67-85. 10.1097/00125480-199801000-00051, 9868514.
32. Yamaguchi U, Hasegawa T. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment]. Gan To Kagaku Ryoho 2004, 31(9):1340-5.
33. Meis-Kindblom JM, Bjerkehage B, Bohling T, Domanski H, Halvorsen TB, Larsson O, et al. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl 1999, 285:18-26.
34. Presant CA, Russell WO, Alexander RW, Fu YS. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol 1986, 4(11):1658-61.
35. Randall RL, Bruckner JD, Papenhausen MD, Thurman T, Conrad EU. Errors in diagnosis and margin determination of soft-tissue sarcomas initially treated at non-tertiary centers. Orthopedics 2004, 27(2):209-12.
36. Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, et al. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 1989, 64(2):484-90. 10.1002/1097-0142(19890715)64:2<484::AID-CNCR2820640223>3.0.CO;2-T, 2736494.
37. Westra WH, Kronz JD, Eisele DW. The impact of second opinion surgical pathology on the practice of head and neck surgery: a decade experience at a large referral hospital. Head Neck 2002, 24(7):684-93. 10.1002/hed.10105, 12112543.
38. Matasar MJ, Shi W, Silberstien J, et al. Expert second opinion pathology review of lymphoma in the Era of the world health organization classification. Blood 2007,
39. Piver MS, Tsukada Y, Werness BA, Dicioccio RA, Whittemore AS, Ponder BA. Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecol Oncol 2000, 78(2):166-70. 10.1006/gyno.2000.5840, 10926797.